Clearmind Medicine Inc. - Common Shares, no par value per share (CMND)

Historical Holders from Q4 2023 to Q3 2025

Type / Class
Equity / Common Shares, no par value per share
Symbol
CMND on Nasdaq
Shares outstanding
59,983,922
Price per share
$1.02
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
281,131
Total reported value
$288,305
% of total 13F portfolios
0%
Share change
-308,289
Value change
-$5,253,781
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
7
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
L.I.A. Pure Capital Ltd 10% -0.2% $956,864 +$427,697 5,980,397 +81% L.I.A. Pure Capital Ltd. 03 Dec 2025
Capitalink Ltd. 10% -0.2% $956,864 +$427,697 5,980,397 +81% Capitalink Ltd. 03 Dec 2025
Daniel Nissim 10% $3,009,635 3,307,291 Nissim Daniel 19 Nov 2025
Iroquois Capital Management, LLC 9.9% +62% $549,158 +$138,124 603,470 +34% Richard Abbe 30 Sep 2025
AdvisorShares Trust 4.8% $201,814 205,933 AdvisorShares Trust 30 Jun 2025
As of 30 Sep 2025, Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) has 7 institutional shareholders filing 13F forms. They hold 281,131 shares. of 59,983,922 outstanding shares (0.47%) .

Institutional Holders of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 281,131 $288,305 -$5,253,781 102.5% 7
2025 Q2 589,420 $5,512,426 +$2,832 89.87% 9
2025 Q1 601,775 $5,452,442 -$30,387 103.5% 7
2024 Q4 612,804 $5,491,207 -$46,685 138% 9
2024 Q3 702,419 $5,494,319 +$5,284,117 122% 8
2024 Q2 165,796 $276,008 +$33,327 168% 4
2024 Q1 153,477 $175,314 +$69,645 114% 4
2023 Q4 92,693 $260,467 +$260,467 281% 1